Biomaterials innovator PACT has raised €17.2 million ($20 million) in Series A funding to accelerate the commercial launch of Oval, its collagen-based, sustainable alternative to plastic-coated textiles.
The round was co-led by Forbion (via its BioEconomy Fund I) and HV Capital, with participation from existing investors.
Pioneering Biomaterials for a Post-Plastic Future
Founded by Dr. Yudí Ding, PACT develops next-generation biomaterials that merge scientific innovation, sustainability, and design. The company’s flagship material, Oval, is engineered from surplus cosmetic-grade collagen, herbal extracts, and natural oils — creating a scalable, traceable, and high-performance substitute for conventional plastics in textiles.
Manufactured through roll-to-roll production, Oval is designed as a drop-in replacement compatible with existing supply chains across fashion, interiors, footwear, and automotive industries.
“I’ve always been obsessed with creating materials that are not only functional and kind to the planet but also inherently beautiful — gentle on the skin, supple, and pleasing to touch,” said Dr. Yudí Ding, co-founder and CEO of PACT.
“The real challenge isn’t inventing new materials in the lab — it’s scaling them to industrial standards. From day one, we’ve treated scalability as core to innovation.”
Advertisement
Backing from Leading Global Investors
Forbion, which manages around €5 billion across funds in the Netherlands, Germany, and the U.S., invests in companies advancing sustainable and biotechnological breakthroughs.
“PACT has combined scientific rigour with design excellence to create a biomaterial platform that meets the highest standards of performance, sustainability, and scalability,” said Joy Faucher, Partner at Forbion BioEconomy.
“Oval has the potential to redefine how global brands source and use materials, offering a credible, commercially viable alternative to plastic-coated textiles and beyond.”
HV Capital, one of Europe’s leading early-stage and growth investors, joins the round following its track record of backing over 250 companies with €2.8 billion invested across nine fund generations.
“We’re thrilled to support PACT as they show how sustainable materials can scale across mainstream markets,” said Maxi Pethö-Schramm, Principal at HV Capital.
“Their formulations integrate directly into existing manufacturing infrastructure — enabling true replacement of high-volume SKUs, not just niche eco-collections. Yudí and the team’s rare mix of technical depth and fashion sensibility positions PACT to lead the material transition at scale.”
Scaling Sustainable Production
PACT recently opened a 13,000-square-foot facility in Cambridge equipped with advanced labs and pilot-scale production lines. The new funding will help the company:
- Expand Oval’s production capacity;
- Accelerate commercial partnerships with global brands; and
- Extend its reach into interiors, footwear, and automotive markets.
The timing aligns with new EU sustainability regulations that are pushing brands toward greater transparency and eco-friendly sourcing.
About PACT
PACT is a Cambridge-based biomaterials company developing collagen-based, plastic-free alternatives for textiles and consumer goods. Its proprietary platform combines biotechnology and natural design to deliver scalable, high-performance materials for global brands.
